174 related articles for article (PubMed ID: 34782599)
21. Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results From a Randomized Phase II Multicenter Clinical Trial (COACT 1001).
Park YK; Yoon HM; Kim YW; Park JY; Ryu KW; Lee YJ; Jeong O; Yoon KY; Lee JH; Lee SE; Yu W; Jeong SH; Kim T; Kim S; Nam BH;
Ann Surg; 2018 Apr; 267(4):638-645. PubMed ID: 28187041
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
Beeharry MK; Zhu ZL; Liu WT; Yao XX; Yan M; Zhu ZG
BMC Cancer; 2019 Sep; 19(1):932. PubMed ID: 31533660
[TBL] [Abstract][Full Text] [Related]
23. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.
Glehen O; Passot G; Villeneuve L; Vaudoyer D; Bin-Dorel S; Boschetti G; Piaton E; Garofalo A
BMC Cancer; 2014 Mar; 14():183. PubMed ID: 24628950
[TBL] [Abstract][Full Text] [Related]
24. Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy.
Shim HJ; Kim HJ; Lee SH; Bae WK; Hwang EC; Cho SH; Chung IJ; Bang HJ; Hwang JE
Sci Rep; 2020 Jun; 10(1):9549. PubMed ID: 32533084
[TBL] [Abstract][Full Text] [Related]
25. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.
Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T
Cancer; 1999 Feb; 85(3):529-34. PubMed ID: 10091726
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
Hyung WJ; Yang HK; Park YK; Lee HJ; An JY; Kim W; Kim HI; Kim HH; Ryu SW; Hur H; Kim MC; Kong SH; Cho GS; Kim JJ; Park DJ; Ryu KW; Kim YW; Kim JW; Lee JH; Han SU;
J Clin Oncol; 2020 Oct; 38(28):3304-3313. PubMed ID: 32816629
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology.
Cabalag CS; Chan ST; Kaneko Y; Duong CP
Gastric Cancer; 2015 Jan; 18(1):11-22. PubMed ID: 24890254
[TBL] [Abstract][Full Text] [Related]
29. Oncologic outcomes of laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective cohort study from China.
Hu Y; Ying M; Huang C; Wei H; Jiang Z; Peng X; Hu J; Du X; Wang B; Lin F; Xu J; Dong G; Mou T; Li G;
Surg Endosc; 2014 Jul; 28(7):2048-56. PubMed ID: 24651893
[TBL] [Abstract][Full Text] [Related]
30. [Curative effect of radical gastrectomy combined with peritoneal lavage with thermal hypoosmotic solution in treatment of gastric cancer].
Chen J; Wang S; Xu H
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(12):730-2. PubMed ID: 11798956
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore.
Chuwa EW; Khin LW; Chan WH; Ong HS; Wong WK
Gastric Cancer; 2005; 8(4):228-37. PubMed ID: 16328597
[TBL] [Abstract][Full Text] [Related]
33. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
[TBL] [Abstract][Full Text] [Related]
35. [Key points of perioperative whole-process management for patients with advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):115-122. PubMed ID: 32074789
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study on surgical method and prognosis in diffuse-type advanced gastric cancer].
Yang J; Li L; Zhang G; Zhou H; Yu Z; Jiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):151-7. PubMed ID: 26932212
[TBL] [Abstract][Full Text] [Related]
37. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
Kurokawa Y; Doki Y; Mizusawa J; Terashima M; Katai H; Yoshikawa T; Kimura Y; Takiguchi S; Nishida Y; Fukushima N; Iwasaki Y; Kaji M; Hirao M; Katayama H; Sasako M
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):460-468. PubMed ID: 29709558
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer.
Satoh S; Okabe H; Teramukai S; Hasegawa S; Ozaki N; Ueda S; Tsuji A; Sakabayashi S; Fukushima M; Sakai Y
Gastric Cancer; 2012 Jan; 15(1):61-9. PubMed ID: 21667134
[TBL] [Abstract][Full Text] [Related]
39. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial.
Tamura S; Fujiwara Y; Kimura Y; Fujita J; Imamura H; Kinuta M; Yano M; Hiratsuka M; Kobayashi K; Okada K; Mori M; Doki Y
J Surg Oncol; 2014 Feb; 109(2):75-80. PubMed ID: 24155213
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
